Home > Insider Trading > Filing (0000884905-13-000074)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
884905	Praxair Inc	PX	Industrial Inorganic Chemicals (2810)	061249050

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1411350	F Eduardo Menezes	C/O Praxair, Inc. 30 Old Ridgebury Road Danbury CT 06810-5113	Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-05-03	23,000	$44.25	38,916	No	4	M	Direct
Common Stock	Disposition	2013-05-03	15,725	$115.24	23,191	No	4	F	Direct
Common Stock	Acquisiton	2013-05-03	25,000	$53.98	48,191	No	4	M	Direct
Common Stock	Disposition	2013-05-03	11,637	$115.17	36,554	No	4	F	Direct
Common Stock	Disposition	2013-05-03	9,000	$115.20	27,554	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2013-05-03	23,000	$0.00	23,000	$44.25
Common Stock	Stock Option (right to buy)	Disposition	2013-05-03	25,000	$0.00	25,000	$53.98

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2006-02-22	2015-02-22	No	4	M	Direct
0	2007-02-28	2016-02-29	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,206	Indirect	401(k)

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$61.47	2008-02-27	2017-02-27	25,000	25,000	Direct
Common Stock	Stock Option (right to buy)	$83.89	2009-02-26	2018-02-26	16,000	16,000	Direct
Common Stock	Stock Option (right to buy)	$60.92	2010-02-24	2019-02-24	31,130	31,130	Direct
Common Stock	Stock Option (right to buy)	$76.16	2011-02-23	2020-02-23	19,610	19,610	Direct
Common Stock	Stock Option (right to buy)	$97.84	2012-02-22	2021-02-22	42,880	42,880	Direct
Common Stock	Stock Option (right to buy)	$109.68	2013-02-28	2022-02-28	43,005	43,005	Direct
Common Stock	Stock Option (right to buy)	$110.58	2014-02-26	2023-02-26	35,220	35,220	Direct
Common Stock	Deferred Stock	$0.00			377	377	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2017-02-27	25,000	25,000	Direct
2018-02-26	16,000	16,000	Direct
2019-02-24	31,130	31,130	Direct
2020-02-23	19,610	19,610	Direct
2021-02-22	42,880	42,880	Direct
2022-02-28	43,005	43,005	Direct
2023-02-26	35,220	35,220	Direct
	377	377	Direct

Footnotes

This total includes shares preveiusly acquired through automatic dividend reinvestment under the Praxair Dividend Reinvestment and Stock Purchase Plan.
Shares of common stock withheld from stock option exercise to cover the option exercise price and tax withholdings. The reporting person retained 11,638 shares net of these shares withheld and 9,000 shares sold.
The $115.202 price reported is the weighted average sale price. The actual sale prices ranged from $115.19 to $115.21 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
This option vests over three years in three consecutive equal annual installments beginning on February 22, 2012.
This option vests over three years in three consecutive equal annual installments beginning on February 28, 2013.
This option vests over three years in three consecutive equal annual installments beginning on February 26, 2014.
Conversion to Praxair Common Stock is on a 1-for-1 basis.
Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferred Program") and are to be settled in Praxair Common Stock.